质量即生命 — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

成为合作伙伴
ALIOLAPARIB
Rx
肿瘤学 & 血液学

ALIOLAPARIB

奥拉帕利 (Olaparib)
Generic (INN)
奥拉帕利 (Olaparib)
Strength
150 mg
Packaging
120 片/瓶。
Indication
卵巢癌：BRCAm 或 HRD 阳性的晚期卵巢癌，或 BRCAm 复发性卵巢癌。
Registration No.
To be added
Package Insert
English & Lao (PDF)
Documents
Registration certificateTo be added
Medicine safety & reporting

More in 肿瘤学 & 血液学

View all →
ALIREVMENI 25mg
ALIREVMENI 25mg
枸橼酸瑞伏美尼 (Revumenib citrate)
ALITRAMETINIB
ALITRAMETINIB
曲美替尼 (Trametinib)
ALIEITROBPA
ALIEITROBPA
艾曲泊帕乙醇胺 (Eltrombopag olamine)
ALISELINISO
ALISELINISO
塞利尼索 (Selinexor)
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Stem Cell CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Stem Cell Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文